0
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

MRI Radiomics Combined with Clinicopathological Factors for Predicting 3-Year Overall Survival of Hepatocellular Carcinoma After Hepatectomy

, , , , , ORCID Icon, , , & show all
Pages 1445-1457 | Received 26 Feb 2024, Accepted 24 Jun 2024, Published online: 23 Jul 2024

References

  • Siegel RL, Miller KD, Fuchs HE, et al. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.21654
  • Li Q, Zhu H. Donafenib treatment for hepatocellular carcinoma. Medicine. 2021;100(25). doi:10.1097/md.0000000000026373
  • Kim S, Shin J, Kim D-Y, et al. Radiomics on gadoxetic acid–enhanced magnetic resonance imaging for prediction of postoperative early and late recurrence of single hepatocellular carcinoma. Clin Cancer Res. 2019;25(13):3847–3855. doi:10.1158/1078-0432.Ccr-18-2861
  • Zhang Z, Jiang H, Chen J, et al. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction. Cancer Imaging. 2019;19(1). doi:10.1186/s40644-019-0209-5
  • Hu J, Wang N, Yang Y, et al. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma. BMC Gastroenterol. 2018;18(1):186. doi:10.1186/s12876-018-0908-6
  • Tzartzeva K, Obi J, Rich NE, et al. Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis. Gastroenterology. 2018;154(6):1706–1718e1701. doi:10.1053/j.gastro.2018.01.064
  • Ding Y, Liu K, Xu Y, et al. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma. Cancer Med. 2020;9(9):3057–3069. doi:10.1002/cam4.2968
  • Ozdemir F, Baskiran A. The importance of AFP in liver transplantation for HCC. J Gastrointest Cancer. 2020;51(4):1127–1132. doi:10.1007/s12029-020-00486-w
  • Qian L, Liang Z, Wang Z, et al. Cellular gp96 upregulates AFP expression by blocking NR5A2 SUMOylation and ubiquitination in hepatocellular carcinoma. J Mol Cell Biol. 2023;15(5). doi:10.1093/jmcb/mjad027
  • Cao Y, Ke R, Wang S, et al. DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma. Oncol Lett. 2017;13(6):4109–4116. doi:10.3892/ol.2017.5999
  • H-H L, L-N Q, Ma L, et al. Effect of KI-67 positive cellular index on prognosis after hepatectomy in Barcelona clinic liver cancer stage A and B hepatocellular carcinoma with microvascular invasion. Onco Targets Ther. 2018;11:4747–4754. doi:10.2147/ott.S165244
  • Zhang X, Wu Z, Peng Y, et al. Correlationship between Ki67, VEGF, and p53 and hepatocellular carcinoma recurrence in liver transplant patients. Biomed Res. Int. 2021;2021:1–7. doi:10.1155/2021/6651397
  • Zhang L, Kuang S, Chen J, et al. The role of preoperative dynamic contrast-enhanced 3.0-T MR imaging in predicting early recurrence in patients with early-stage hepatocellular carcinomas after curative resection. Front Oncol. 2019;9:1336. doi:10.3389/fonc.2019.01336
  • Min JH, Lee MW, Park HS, et al. Interobserver variability and diagnostic performance of gadoxetic acid-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma. Radiology. 2020;297(3):573–581. doi:10.1148/radiol.2020201940
  • Song L, Li J, Luo Y. The importance of a nonsmooth tumor margin and incomplete tumor capsule in predicting HCC microvascular invasion on preoperative imaging examination: a systematic review and meta-analysis. Clin Imaging. 2021;76:77–82. doi:10.1016/j.clinimag.2020.11.057
  • Hui TCH, Chuah TK, Low HM, et al. Predicting early recurrence of hepatocellular carcinoma with texture analysis of preoperative MRI: a radiomics study. Clin Radiol. 2018;73(12):1056.e1011–1056.e1016. doi:10.1016/j.crad.2018.07.109
  • Yu Y, Fan Y, Wang X, et al. Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma. Eur Radiol. 2021;32(2):959–970. doi:10.1007/s00330-021-08250-9
  • Wang L, Feng B, Wang S, et al. Diagnostic value of whole-tumor apparent diffusion coefficient map radiomics analysis in predicting early recurrence of solitary hepatocellular carcinoma ≤ 5 cm. Abdom Radiol. 2022;47(9):3290–3300. doi:10.1007/s00261-022-03582-6
  • Wang X-H, Long L-H, Cui Y, et al. MRI-based radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma. Br J Cancer. 2020;122(7):978–985. doi:10.1038/s41416-019-0706-0
  • Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2
  • Wei YZ, Huang YQ, Zeng SY, et al. 基于SEER数据库第8版肝癌AJCC分期的验证及改良 [Validation and modification of AJCC 8th edition staging system for hepatocellular carcinoma--analysis based on SEER database]. Zhonghua Yi Xue Za Zhi. 2021;101(28):2216–2222. Chinese. doi:10.3760/cma.j.cn112137-20201231-03527
  • Xia TY, Zhou ZH, Meng XP, et al. Predicting microvascular invasion in hepatocellular carcinoma using CT-based radiomics model. Radiology. 2023;307(4):e222729. doi:10.1148/radiol.222729
  • Hu X, Zhou J, Li Y, et al. Added value of viscoelasticity for MRI-Based Prediction of Ki-67 expression of hepatocellular carcinoma using a deep learning combined radiomics (DLCR) model. Cancers. 2022;14(11):2575. doi:10.3390/cancers14112575
  • Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–446. doi:10.1016/j.ejca.2011.11.036
  • Zech CJ, Ba-Ssalamah A, Berg T, et al. Consensus report from the 8th international forum for liver magnetic resonance imaging. Eur Radiol. 2020;30(1):370–382. doi:10.1007/s00330-019-06369-4
  • Koh DM, Ba-Ssalamah A, Brancatelli G, et al. Consensus report from the 9(th) international forum for liver magnetic resonance imaging: applications of gadoxetic acid-enhanced imaging. Eur Radiol. 2021;31(8):5615–5628. doi:10.1007/s00330-020-07637-4
  • Liang G, Yu W, Liu S, et al. The diagnostic performance of radiomics-based MRI in predicting microvascular invasion in hepatocellular carcinoma: a meta-analysis. Front Oncol. 2022;12:960944. doi:10.3389/fonc.2022.960944
  • Zhang J, Wang X, Zhang L, et al. Radiomics predict postoperative survival of patients with primary liver cancer with different pathological types. Ann Transl Med. 2020;8(13):820. doi:10.21037/atm-19-4668
  • Zhen Z, Shen Z, Hu Y, et al. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis. Aging. 2021;13(13):17707–17733. doi:10.18632/aging.203260
  • Arizumi T, Ueshima K, Chishina H, et al. Decreased blood flow after sorafenib administration is an imaging biomarker to predict overall survival in patients with advanced hepatocellular carcinoma. Dig Dis. 2014;32(6):733–739. doi:10.1159/000368013
  • Zhu YJ, Feng B, Wang S, et al. Model-based three-dimensional texture analysis of contrast-enhanced magnetic resonance imaging as a potential tool for preoperative prediction of microvascular invasion in hepatocellular carcinoma. Oncol Lett. 2019;18(1):720–732. doi:10.3892/ol.2019.10378
  • Lubner MG, Smith AD, Sandrasegaran K, et al. CT texture analysis: definitions, applications, biologic correlates, and challenges. Radiographics. 2017;37(5):1483–1503. doi:10.1148/rg.2017170056